DK1480625T3 - Transdermalt system med fentanyl - Google Patents

Transdermalt system med fentanyl

Info

Publication number
DK1480625T3
DK1480625T3 DK03743380T DK03743380T DK1480625T3 DK 1480625 T3 DK1480625 T3 DK 1480625T3 DK 03743380 T DK03743380 T DK 03743380T DK 03743380 T DK03743380 T DK 03743380T DK 1480625 T3 DK1480625 T3 DK 1480625T3
Authority
DK
Denmark
Prior art keywords
substrate
transdermal system
fentanyl
active ingredient
mixture
Prior art date
Application number
DK03743380T
Other languages
Danish (da)
English (en)
Inventor
Katalin Tisa-Bostedt
Wilfried Fischer
Christian Leichs
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27771006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1480625(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK1480625T3 publication Critical patent/DK1480625T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK03743380T 2002-03-06 2003-03-05 Transdermalt system med fentanyl DK1480625T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10209724 2002-03-06
PCT/EP2003/002249 WO2003074035A1 (fr) 2002-03-06 2003-03-05 Systeme transdermique au fentanyle

Publications (1)

Publication Number Publication Date
DK1480625T3 true DK1480625T3 (da) 2008-10-27

Family

ID=27771006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03743380T DK1480625T3 (da) 2002-03-06 2003-03-05 Transdermalt system med fentanyl

Country Status (10)

Country Link
US (2) US20040001882A1 (fr)
EP (1) EP1480625B1 (fr)
AT (1) ATE403420T1 (fr)
AU (1) AU2003210417B2 (fr)
CA (1) CA2477120C (fr)
DE (1) DE50310279D1 (fr)
DK (1) DK1480625T3 (fr)
ES (1) ES2307955T3 (fr)
PT (1) PT1480625E (fr)
WO (1) WO2003074035A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
ATE364380T1 (de) * 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
EP1611882B1 (fr) * 2004-06-01 2010-04-07 Hisamitsu Pharmaceutical Co., Inc. Patch adhésif
US8246977B2 (en) 2004-10-21 2012-08-21 Durect Corporation Transdermal delivery systems
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US20070098772A1 (en) * 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
EP2308480B1 (fr) 2005-09-23 2014-08-13 ALZA Corporation Formulation de polyacrylate hautement chargée en activateur pour des applications transdermiques
WO2007035941A2 (fr) * 2005-09-23 2007-03-29 Alza Corporation Systeme d'administration transdermique de galantamine
DE102006048130A1 (de) * 2006-10-06 2008-04-10 Axxonis Pharma Ag Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
CN104398496B (zh) * 2007-10-15 2018-03-20 阿尔扎公司 芬太尼的一天更换一次透皮施用
DE102008006210A1 (de) * 2008-01-26 2009-07-30 Lts Lohmann Therapie-Systeme Ag Kosmetisches Fixierpflaster
EP2462927A1 (fr) 2010-12-03 2012-06-13 Hexal AG Système thérapeutique transdermique comportant du fentanyl
JP6940407B2 (ja) 2014-12-19 2021-09-29 キンデーバ ドラッグ デリバリー リミティド パートナーシップ フェンタニルを含む経皮薬物送達デバイス

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5356811A (en) * 1992-04-21 1994-10-18 Coats Billy C Method of processing stabilized aloe vera gel obtained from the whole aloe vera leaf
DE19708674C2 (de) * 1996-03-25 2002-02-07 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer wirkstoffhaltigen Filmschicht und einer löslichen Trennschicht, sowie ein Verfahren zu dessen Herstellung
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
DE19654468C1 (de) * 1996-12-27 1998-01-22 Lohmann Therapie Syst Lts Extrem flexibles, dermal oder transdermal wirkendes Pflaster und Verfahren zu seiner Herstellung
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
KR100674108B1 (ko) * 1999-04-13 2007-01-26 히사미쓰 세이야꾸 가부시키가이샤 경피흡수형 제제
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof

Also Published As

Publication number Publication date
CA2477120C (fr) 2011-06-14
US20080113012A1 (en) 2008-05-15
EP1480625A1 (fr) 2004-12-01
CA2477120A1 (fr) 2003-09-12
PT1480625E (pt) 2008-08-29
DE50310279D1 (de) 2008-09-18
AU2003210417B2 (en) 2007-10-11
WO2003074035A1 (fr) 2003-09-12
EP1480625B1 (fr) 2008-08-06
ATE403420T1 (de) 2008-08-15
AU2003210417A1 (en) 2003-09-16
US20040001882A1 (en) 2004-01-01
ES2307955T3 (es) 2008-12-01

Similar Documents

Publication Publication Date Title
DK1480625T3 (da) Transdermalt system med fentanyl
NO20063171L (no) Endoparasitisidale sammensetninger for topisk anvendelse
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0409900A (pt) produtos laminados com padrão
UY27720A1 (es) Aroilpiridinonas monocíclicas,
ATE506969T1 (de) Stabile zusammensetzungen zur topischen arzneimittelabgabe
WO2005110428A3 (fr) Inhibiteurs de protéase rétrovirale repoussant leur résistance
EA200701036A1 (ru) Лактамные соединения и их применение в качестве фармацевтических препаратов
WO2006110527A3 (fr) Systeme de bande de contention
DK1079813T3 (da) Farmaceutisk bæreranordning, der er egnet til administration af farmaceutiske forbindelser til slimhindeoverflader
ATE517616T1 (de) Faserfreies transdermales therapeutisches system und verfahren zu seiner herstellung
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
WO2004041269A3 (fr) Nouvel emploi pour composition pharmaceutique
SG152257A1 (en) Topical preparation containing ambroxol
BRPI0307777B8 (pt) emplastro transdérmico
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
BRPI0309651B8 (pt) método para prevenir ou reduzir a resistência a um pesticida de uma peste de substrato, composição de pesticida, uso dos mesmos, e, método para preparar uma composição de pesticida
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
WO2006042625A3 (fr) Compositions comprenant des inhibiteurs de la synthese de la prostaglandine et/ou du leucotriene en combinaison avec des stimulateurs de liberation de neuromediateurs cutanes
WO2005117871A3 (fr) Compostions pharmaceutiques pour le traitement d'un prurit
BRPI0518554A2 (pt) uso de um inibidor de pde3
EP1584335A3 (fr) Combinaison de substances actives comprenant un composé carbinol et un opioïde